Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2017 (2017), Article ID 3615354, 5 pages
https://doi.org/10.1155/2017/3615354
Case Report

Serum Cytokine Profile in a Patient Diagnosed with Dysferlinopathy

1Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia
2University of Nevada, Reno, Reno, NV, USA
3Kirov Military Medical Academy, Saint Petersburg, Russia
4Human Stem Cell Institute, Moscow, Russia
5Ryazan State Medical University Named after Academician I. P. Pavlov, Ryazan, Russia

Correspondence should be addressed to Albert A. Rizvanov; ur.ufpk@vonavzir.trebla

Received 4 January 2017; Accepted 28 March 2017; Published 13 April 2017

Academic Editor: André Talvani

Copyright © 2017 Svetlana F. Khaiboullina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Moore, C. J. Shilling, S. Westra et al., “Limb-girdle muscular dystrophy in the United States,” Journal of Neuropathology & Experimental Neurology, vol. 65, no. 10, pp. 995–1003, 2006. View at Google Scholar
  2. E. M. McNally, C. Ly, H. Rosenmann et al., “Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation,” American Journal of Medical Genetics, vol. 91, no. 4, pp. 305–312, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. M. C. Dalakas, “Pathogenesis and therapies of immune-mediated myopathies,” Autoimmunity Reviews, vol. 11, no. 3, pp. 203–206, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Dalakas and R. Hohlfeld, “Polymyositis and dermatomyositis,” The Lancet, vol. 362, no. 9388, pp. 971–982, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Rawat, T. V. Cohen, B. Ampong et al., “Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle,” American Journal of Pathology, vol. 176, no. 6, pp. 2891–2900, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Lundberg, J. M. Brengman, and A. G. Engel, “Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls,” Journal of Neuroimmunology, vol. 63, no. 1, pp. 9–16, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Lundberg, A.-K. Ulfgren, P. Nyberg, U. Andersson, and L. Klareskog, “Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies,” Arthritis and Rheumatism, vol. 40, no. 5, pp. 865–874, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Page, G. Chevrel, and P. Miossec, “Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells,” Arthritis and Rheumatism, vol. 50, no. 1, pp. 199–208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Lee, A. Awasthi, N. Yosef et al., “Induction and molecular signature of pathogenic TH17 cells,” Nature Immunology, vol. 13, no. 10, pp. 991–999, 2012. View at Publisher · View at Google Scholar
  10. A. Lehtonen, S. Matikainen, M. Miettinen, and I. Julkunen, “Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation,” Journal of Leukocyte Biology, vol. 71, no. 3, pp. 511–519, 2002. View at Google Scholar · View at Scopus
  11. T. Schroder, J. Fuchss, I. Schneider, G. Stoltenburg-Didinger, and F. Hanisch, “Eosinophils in hereditary and inflammatory myopathies,” Acta Myologica, vol. 32, no. 3, pp. 148–153, 2013. View at Google Scholar
  12. R. T. Palframan, P. D. Collins, T. J. Williams, and S. M. Rankin, “Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow,” Blood, vol. 91, no. 7, pp. 2240–2248, 1998. View at Google Scholar · View at Scopus
  13. M. E. Rothenberg, R. Ownbey, P. D. Mehlhop et al., “Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice,” Molecular Medicine, vol. 2, no. 3, pp. 334–348, 1996. View at Google Scholar · View at Scopus
  14. R. Alam, S. Stafford, P. Forsythe et al., “RANTES is a chemotactic and activating factor for human eosinophils,” Journal of Immunology, vol. 150, no. 8, part 1, pp. 3442–3448, 1993. View at Google Scholar · View at Scopus
  15. R. A. J. Warringa, L. Koenderman, P. T. M. Kok, J. Kruekniet, and P. L. B. Bruijnzeel, “Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3,” Blood, vol. 77, no. 12, pp. 2694–2700, 1991. View at Google Scholar · View at Scopus
  16. J. Venge, M. Lampinen, L. Håkansson, S. Rak, and P. Venge, “Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung,” Journal of Allergy and Clinical Immunology, vol. 97, no. 5, pp. 1110–1115, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Van Weel, M. M. L. Deckers, J. M. Grimbergen et al., “Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo,” Circulation Research, vol. 95, no. 1, pp. 58–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Mackenzie and C. Ruhrberg, “Diverse roles for VEGF-A in the nervous system,” Development, vol. 139, no. 8, pp. 1371–1380, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Boyman and J. Sprent, “The role of interleukin-2 during homeostasis and activation of the immune system,” Nature Reviews Immunology, vol. 12, no. 3, pp. 180–190, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Liao, J.-X. Lin, and W. J. Leonard, “IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation,” Current Opinion in Immunology, vol. 23, no. 5, pp. 598–604, 2011. View at Publisher · View at Google Scholar · View at Scopus